Logo for 111 Inc

111 Investor Relations Material

Latest events

Logo for 111 Inc

Status Update

111
Logo for 111

Status Update

26 Mar, 2025
Logo for 111

Q4 2024

20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from 111 Inc

Access all reports
111, Inc. operates as a digital healthcare platform in China, focusing on connecting patients with pharmaceutical products and healthcare services through both online and offline channels. The company operates in two main segments: B2C (business-to-consumer) and B2B (business-to-business). The B2C segment includes online retail of prescription and over-the-counter drugs, nutritional supplements, medical supplies, and personal care products. The B2B segment involves an online wholesale pharmacy platform that serves other pharmacies and healthcare providers. Additionally, 111, Inc. offers online consultation, electronic prescription services, and patient management services through its internet hospital. Headquartered in Shanghai, 111, Inc.'s shares are listed on the NASDAQ.